AIDS News and Research

RSS

GHIT Fund invests in two innovative malaria eradication tools

The Global Health Innovative Technology Fund (GHIT Fund) announced today that it’s investing US$1,383,785 in a pair of innovative malaria eradication tools—a vaccine that could block transmission of two species of the deadly disease and a rapid field test that can reveal a malaria infection in minutes.

1 Apr 2016

Protease inhibitors may prevent cardiovascular disease risk caused by HIV medications

According to the World Health Organization, approximately 37 million people are living with HIV. Antiviral medications are used to control the disease and prevent its progression to AIDS.

29 Mar 2016

Engineered HIV vaccine protein may prevent HIV infection

Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" antibodies that can prevent HIV infection.

28 Mar 2016

IBM's World Community Grid supports TB eradication project

The University of Nottingham is launching a new study to address tuberculosis (TB), one of the world's most deadly diseases, supported by IBM's World Community Grid -- one of the most powerful and fastest virtual supercomputers on the planet.

25 Mar 2016

Virus-generated DNA lurking between human genes, show research

Think your DNA is all human? Think again. And a new discovery suggests it's even less human than scientists previously thought.

24 Mar 2016

Engineered vaginal Lactobacilli could reduce heterosexual HIV-1 transmission in women

A normal, predominant bacterial species of the healthy vaginal microbiota can be engineered for potential use as a novel protective agent against HIV-1 transmission in women, according to a new publication from scientists at Osel, Inc. and their collaborators.

24 Mar 2016

Study suggests strong treatment programs can help make headway against AIDS epidemic

Botswana appears to have achieved very high rates of HIV diagnosis, treatment, and viral suppression--much better than most Western nations, including the United States--according to a new study from Harvard T.H. Chan School of Public Health and colleagues in Botswana.

24 Mar 2016

USC's Keck School of Medicine researcher named recipient of NCI Outstanding Investigator Award

Distinguished Professor Jae Jung, PhD, chair of the Department of Molecular Microbiology & Immunology and the director of the University of Southern California Institute for Emerging Pathogens and Immune Diseases at the Keck School of Medicine of USC, is among this year's recipients of the National Cancer Institute Outstanding Investigator Award.

23 Mar 2016

World TB Day 2016: WHO calls to Unite to End TB

In advance of World TB Day, to be observed on 24 March, the World Health Organization is calling on countries and partners to Unite to End TB.

22 Mar 2016

Specialized gene editing system paves way to eventual cure for HIV patients

A specialized gene editing system designed by scientists at the Lewis Katz School of Medicine at Temple University is paving the way to an eventual cure for patients infected with HIV, the virus that causes AIDS.

22 Mar 2016

Researchers develop conceptual model to help LGBTQ patients with multiple minority identities

Lesbian, gay, bisexual, transgender and queer (LGBTQ) patients who are also racial and ethnic minorities suffer significant health disparities, while facing more complicated challenges than white LGBTQ or racial and ethnic minority patients alone.

21 Mar 2016

Simple TB screening and isoniazid can be effective for HIV patients at risk for TB

The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to address this deadly co-infection. But TB is harder to detect in HIV-infected patients and diagnostic test results take time, so many healthcare providers prescribe multi-drug TB treatments as a precaution.

20 Mar 2016

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study -- a 10-nation, randomized clinical trial of adult outpatients -- investigators concluded that there was no added benefit of using four drugs for TB over just using one drug, isoniazid, to save lives in people with advanced HIV/AIDS.

18 Mar 2016

USF receives $9 million NIH grant to study unique treatment for age-related hearing loss

Researchers in the University of South Florida's Global Center for Hearing and Speech Research, recognized as the world's top research center for age-related hearing loss, have received a five-year, $9 million grant from the National Institutes of Health to study two unique ways to treat age-related hearing loss (ARHL).

17 Mar 2016

New hearing aid adjustment program may help increase hearing aid use for older adults

Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.

16 Mar 2016

New microfluidic biosensor can identify white blood cells quickly for AIDS diagnosis

Researchers from the University of Illinois at Urbana-Champaign have developed a highly sensitive biosensor based on a differential immuno-capture technology that can detect sub-populations of white blood cells. As part of a small, disposable biochip, the microfluidic biosensor can count CD4+/CD8+ T cells quickly and accurately for AIDS diagnosis in the field.

14 Mar 2016

Eclipse Aesthetics partners with Skincential Sciences to distribute Clearista product line

Eclipse Aesthetics, LLC has formed a partnership with Skincential Sciences, a medical diagnostics company in southern California. Eclipse will serve as the exclusive distributor for ClearistaPRO, specially formulated products to safely and effectively remove biomarkers from tissue.

13 Mar 2016

PKM2 enzyme plays major role in early steps of wound healing

An enzyme involved in glucose metabolism in cells plays a major role in the early steps of wound healing, a finding that could lead to new therapeutic approaches for wound care, according to researchers at Georgia State University.

11 Mar 2016

Low cost, easy-to-use test could help reduce TB death rate of HIV patients in sub-Saharan Africa

A low cost, easy to use, urine test to diagnose tuberculosis (TB) among patients with HIV could help reduce the TB death rate of HIV-positive patients in hospital, according to a new study published in The Lancet today.

10 Mar 2016

Breastfeeding essential for first six months of newborns' life

Newborns should be breastfed exclusively for the first six months of life with continued breastfeeding until at least 12 months, according to the American Academy of Pediatrics. This can be hard when new breastfeeding families have to rely on child care facilities because of a need to return to work in a specified time. What kind of breastfeeding support, if any, can they rely on from the child care facility? This question interested a team of researchers from the University of Pennsylvania School of Nursing

10 Mar 2016

AIDS News and Research

GHIT Fund invests in two innovative malaria eradication tools

Protease inhibitors may prevent cardiovascular disease risk caused by HIV medications

Engineered HIV vaccine protein may prevent HIV infection

IBM's World Community Grid supports TB eradication project

Virus-generated DNA lurking between human genes, show research

Engineered vaginal Lactobacilli could reduce heterosexual HIV-1 transmission in women

Study suggests strong treatment programs can help make headway against AIDS epidemic

USC's Keck School of Medicine researcher named recipient of NCI Outstanding Investigator Award

World TB Day 2016: WHO calls to Unite to End TB

Specialized gene editing system paves way to eventual cure for HIV patients

Researchers develop conceptual model to help LGBTQ patients with multiple minority identities

Simple TB screening and isoniazid can be effective for HIV patients at risk for TB

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

USF receives $9 million NIH grant to study unique treatment for age-related hearing loss

New hearing aid adjustment program may help increase hearing aid use for older adults

New microfluidic biosensor can identify white blood cells quickly for AIDS diagnosis

Eclipse Aesthetics partners with Skincential Sciences to distribute Clearista product line

PKM2 enzyme plays major role in early steps of wound healing

Low cost, easy-to-use test could help reduce TB death rate of HIV patients in sub-Saharan Africa

Breastfeeding essential for first six months of newborns' life

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News